pentobarbital will minimize the extent or effect of terbinafine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.

pentobarbital will decrease the level or effect of diclofenac by affecting hepatic enzyme CYP2C9/10 metabolism. Insignificant/Significance Not known.

fentanyl intranasal and pentobarbital each increase sedation. Stay clear of or Use Alternate Drug. Restrict use to clients for whom alternative procedure selections are insufficient

pentobarbital will decrease the level or result of midazolam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.

pentobarbital will lessen the extent or result of fostemsavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.

Withdrawal signs and symptoms take place in infants born to moms who get barbiturates all over the very last trimester of pregnancy

pentobarbital will decrease the level or outcome of eplerenone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unfamiliar.

Contraindicated (one)pentobarbital will lessen the extent or influence of elbasvir/grazoprevir by impacting hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will lower the extent or outcome of brexpiprazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Closely. Double brexpiprazole dose above 1-two weeks if administered with a powerful CYP3A4 inducer.

pentobarbital will minimize the extent or result of zaleplon by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Mysterious.

pentobarbital will lower the level or result of pitolisant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Carefully. Pitolisant exposure is decreased by 50% if coadministered with potent CYP3A4 inducers.

pentobarbital will reduce the level or influence of nilotinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.

pentobarbital will lessen the level or effect of midostaurin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Strong CYP3A4 more info inducers might minimize midostaurin concentrations causing decreased efficacy.

pentobarbital will reduce the extent or impact of apremilast by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Coadministration with solid CYP inducers ends in an important minimize of systemic publicity of apremilast, which may result in lack of efficacy